Brand-new painkiller approved by US health agency DW 01/31/2025Suzetrigine, a new painkiller, offers relief without the addictive potential of opioids, marking a significant advancement in pain management.
Pain: recognizing the power of non-pharmaceutical interventionsNon-opioid alternatives like microbiome manipulation and virtual reality could provide new pain management strategies amid the opioid crisis.
FDA OK's painkiller designed to end opioids' addiction and overdose riskJournavx offers a new pain management solution without the addiction risks of opioids.
FDA approves drug from Boston-based company to treat pain without opioid effectsSuzetrigine, a non-addictive pain relief drug, is now approved by the FDA and promises a safer alternative to opioids.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?Suzetrigine is a groundbreaking painkiller approved by the FDA, providing an effective alternative to opioids without addiction risks.
FDA approves non-opioid painkiller designed to eliminate risk of addictionVertex has received FDA approval for Journavx, a pain medication designed to mitigate addiction and overdose risks typically associated with opioids.
Brand-new painkiller approved by US health agency DW 01/31/2025Suzetrigine, a new painkiller, offers relief without the addictive potential of opioids, marking a significant advancement in pain management.
Pain: recognizing the power of non-pharmaceutical interventionsNon-opioid alternatives like microbiome manipulation and virtual reality could provide new pain management strategies amid the opioid crisis.
FDA OK's painkiller designed to end opioids' addiction and overdose riskJournavx offers a new pain management solution without the addiction risks of opioids.
FDA approves drug from Boston-based company to treat pain without opioid effectsSuzetrigine, a non-addictive pain relief drug, is now approved by the FDA and promises a safer alternative to opioids.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?Suzetrigine is a groundbreaking painkiller approved by the FDA, providing an effective alternative to opioids without addiction risks.
FDA approves non-opioid painkiller designed to eliminate risk of addictionVertex has received FDA approval for Journavx, a pain medication designed to mitigate addiction and overdose risks typically associated with opioids.